Our Services
Turn Insights into Strategy
We help define your Product Positioning & Value Proposition through the following deliverables:
- Target Product Profile – Defining a TPP is not a one-time task but an iterative process that turns a scientific concept into a product that can be approved, reimbursed, adopted, and used in practice. Identifying it as early as possible is critical, as it defines the clinical, economic, and practical evidence required for success.
- Market Landscape and Gap Analysis – In-depth research into positioning opportunities, unmet needs, and competitive behavior helps identify gaps between the TPP and payer expectations. This guides evidence generation priorities and provides early warning signals for market access barriers at launch.
- Value Communications – Creation and delivery of global value dossier (GVD) and defining value proposition.
Global Market Access Support
We approach Market Access as a Strategic, Multi-stakeholder Discipline, not a Downstream Technical Exercise.
We provide:
- Strategic Market Access Planning Tools & Methods – Structured support to shape early market access strategies, helping define positioning, evidence requirements, stakeholder engagement plans, and launch readiness from the outset.
- Market Access Strategy Implementation – Practical guidance in preparing and managing submissions to relevant HTA bodies, ensuring evidence packages are aligned with local requirements, value expectations, and reimbursement criteria.
- Actionable insights – Translate complexity into clear strategic choices and practical action plans that can be aligned, owned, and executed effectively by both large cross-functional organizations and small teams
Evidence Generation Plans
We help you to support your Value Propositions with Decision-grade Evidence:
- Evidence Generation Plans – Strategies to address identified evidence gaps to strengthen the evidence base of the product that can address a wide range of PICO definitions.
- Review of Clinical Evidence – Indirect treatment comparisons (ITC), Network meta-analysis (NMA), Natural disease history studies etc.
- Advisory Boards and Clinical Expert Elicitation – We support with the systematic gathering, evaluation, and synthesis of the opinions and insights of clinical experts regarding the position of your product/ therapy within the treatment paradigm.
- Cost effectiveness Analysis (CEA) and Budget Impact Analysis (BIA) – Guidance with the creation and adaptation of models and costing tools.
Stakeholder Analysis & Engagement Plans
We support Companies in Navigating Complex Market Access Environments:
- Stakeholder Analysis & Engagement Plans – Creating and executing strategies for engaging relevant stakeholders, incl. frameworks for stakeholder interest analysis and methods for effective engagement.
- Healthcare Policy Analysis & Shaping – Monitor relevant regional and national policy policy developments and align public affairs strategies to market access goals.
- Payer Research –Pricing analysis, pricing scenario’s, payer ad-boards.
Integration of Market Access goals into Launch Strategy
Avoid Cross-functional Misalignment and Execution Risk, by Fully Integrating Market Access into Launch Planning – tailored to the Organizations’ Resources & Capabilities.
We offer support with
- Strategic Planning Tools & Methods – No ‘one-size fits all’ templates, but tailored to your specific needs
- Market access Organizational Development – Establish an effective market access support structure tailored to your organization’s capabilities and resources.
- Setting Plans into Action – Practical support to achieve market access milestones.
EUHTA/ JCA Preparedness & Support with Reimbursement Applications
We provide Hands-on Support with:
- EUHTA /JCA readiness – Ensure clinical development and evidence plans are aligned with Joint Clinical Assessment (JCA) expectations, including PICO interpretation, comparator strategy, and evidence gap identification.
- Evidence strategy & value positioning – Translate clinical and real-world evidence into a clear value narrative that supports both EU-level HTA assessment and national reimbursement decisions.
- Reimbursement strategy & dossier development – Design pricing and reimbursement strategies and support the preparation of robust reimbursement submissions aligned with HTA requirements.
- Netherlands market access expertise – Extensive experience navigating the Dutch reimbursement landscape, including Zorginstituut Nederland (ZIN), Horizonscan positioning, CieBOM advice, and “sluis” procedures.
- Stakeholder & payer engagement preparation – Prepare companies for interactions with HTA bodies and payers through evidence briefing materials, strategic messaging, and access roadmaps.
Contact Us
If you want to know more about Keen Access Insights’ consulting services or about Transmineo’s developments